semaglutide mississippi MS Attorney General warns Mississippians of the dangers of unapproved weight loss medication Any thoughts on the Mississippi

Altimmune just made a big move in the world of GLP-1 research, but this time, its not about obesity.The company announced yesterday that it has officially begun enrolling participants in a Phase 2 trial of pemvidutide, its GLP-1 and glucagon dual receptor agonist, to evaluate the drug in people with Alcohol Use Disorder, or AUD

See if you qualify now!

The answer, in our new @BMJMedicine, is more interesting than yes or no

She also details what people can do if their access to these drugs has been cut off due to insurance or the FDA ban.

Choose Empower Pharmacy for Ondansetron ODT

Why the weight, and heart risks, return after stopping GLP-1 drugs.